Kaiser Permanente Study Shows That A Larger Abdomen In Midlife Increases Risk Of Dementia
People in their 40s with larger stomachs have a higher risk for dementia when they reach their 70s, according to a study published in the March 26, 2008, online issue of Neurology(R), the medical journal of the American Academy of Neurology. Previous studies have looked at central obesity (as determined by waist circumference) and body mass index in the elderly and its link to dementia risk.
Study Confirms Validity Of Pittsburgh Compound-B In Identifying The Toxins Associated With Alzheimer's Disease
A groundbreaking study conducted by University of Pittsburgh Alzheimer's disease researchers reported in the journal Brain (currently online) confirms that Pittsburgh Compound-B (PiB) binds to the telltale beta-amyloid deposits found in the brains of patients with Alzheimer's disease.
Alzheimer's Society Comment On Research Into Abdominal Obesity And Risk Of Dementia Published In Journal Of The American Academy Of Neurology
We have known for sometime that obesity dramatically increases your risk of developing dementia. This new study highlights that having a large abdomen, regardless of weight, also significantly increases your risk. This is an important piece of research but the results are not that surprising as a large stomach is associated with high blood pressure, cholesterol and diabetes - all major risk factors for dementia.
New Alzheimer's Study Underscores Importance Of Sustaining Viable Medicaid System
The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) said that findings in a new study from the Alzheimer's Association, which estimates ten million U.S.
Signs And Symptoms Of Alzheimer's Disease May Be Reduced By Umbilical Cord Blood Cell Therapy
Targeted immune suppression using human umbilical cord blood cells may improve the pathology associated with Alzheimer's disease, a new study in a mouse model of this currently untreatable neurodegenerative condition reports. The study, led by researchers at the University of South Florida, is published online in the peer-reviewed journal Stem Cells and Development (http://www.
Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression Of Alzheimer's Disease
Stems cells derived from umbilical cord blood are showing early potential in fighting Alzheimer's disease, according to results from a new preclinical study published in the March issue of Stem Cells and Development. The study, conducted by researchers from the University of South Florida and Saneron CCEL Therapeutics, Inc.
Survey Finds 3 In 5 Caregivers Say Their Children Help Care For Loved Ones With Alzheimer's Disease
Results from the third annual Alzheimer's Foundation of America (AFA) ICAN: Investigating Caregivers' Attitudes and Needs Survey suggest that Alzheimer's disease care is a family affair.
Alzheimer's Society Comment On Research Into Hormone Replacement Therapy, Memory Loss And Alzheimer's Disease
Hormone replacement therapy (HRT) cannot be viewed as a treatment option for reducing risk or delaying the onset of Alzheimer's disease. Scientists halted a large clinical trial comparing HRT to a dummy treatment, when results suggested some women taking HRT had an increased risk for breast cancer and cardiovascular disease.
Alzheimer's Society Comment On Paul Burstow MP's Report On The Use Of Antipsychotics In People With Dementia, UK
The overprescribing of antipsychotics to people with dementia is robbing people of their quality of life and is a serious breach of human rights. Paul Burstow MP's report illustrates the scale and severity of the important issue. Inappropriate use of antipsychotics in people with dementia can cause devastating side effects, such as excessive sedation, parkinsonism symptoms, accelerated cognitive decline and an increased risk of stroke.
Alzheimer's Society Comment On New Research Showing That Antipsychotic Drugs Accelerate Cognitive Deterioration In People With Alzheimer's Disease, UK
This important research demonstrates that antipsychotic drugs not only have no long-term benefit for people with dementia, but also cause significant cognitive deterioration. Over 100, 000 people with dementia are currently prescribed antipsychotic drugs.